We’re pleased to participate for a second year in the World Economic Forum in Davos, Switzerland. The agenda for this year: Addressing profound political, economic, social and, above all, technological transformations resulting in a new global context for decision-making. The World Economic Forum’s Annual Meeting convenes global leaders and for our part, Foundation Medicine is pleased to contribute our views, particularly in the area of how molecular information is driving a new paradigm, a new “context,” in cancer care. You can read more about this here.
Worldwide healthcare, technology, educational and financial contributions have brought us to a new place; to a new landscape in cancer care where treatment is informed by a comprehensive knowledge of the molecular drivers of an individual’s unique cancer instead of its location in the body (lung, breast, etc.). This molecular information renaissance will transform the way medicine is practiced and taught, and importantly, it will accelerate better treatment outcomes for patients through a global, interconnected knowledgebase that facilitates real-time collaboration between physicians located in disparate parts of the globe.
The World Economic Forum is a congress of leaders assembled to think big, to drive change, and to impact the global good. At Foundation Medicine, we’re thinking big about the future of cancer care, and the power and promise of comprehensive molecular information to transform and enable this new context in cancer care.